Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- NNNN
- Price
- 28.61
- Stock movement down
- -4.98 (-14.83%)
- Company name
- Anbio Biotechnology Class A Ordinary Shares
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 1.26B
- Ent value
- 1.25B
- Price/Sales
- 70.51
- Price/Book
- 38.83
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 167.35
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
NNNN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 167.35 |
| Price to OCF | 1364.31 |
| Price to FCF | 1364.32 |
| Price to EBITDA | 425.59 |
| EV to EBITDA | 423.52 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 70.51 |
| Price to Book | 38.83 |
| EV to Sales | 70.17 |
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 43.89M |
| EPS (TTM) | 0.17 |
| FCF per share (TTM) | 0.02 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 17.81M |
| Gross profit (TTM) | 12.68M |
| Operating income (TTM) | 6.42M |
| Net income (TTM) | 7.50M |
| EPS (TTM) | 0.17 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 71.20% |
| Operating margin (TTM) | 36.02% |
| Profit margin (TTM) | 42.13% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 6.28M |
| Net receivables | 4.36M |
| Total current assets | 32.49M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 32.49M |
| Accounts payable | 70.84K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 153.92K |
| Total liabilities | 153.92K |
| Shareholder's equity | 32.34M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 920.41K |
| Capital expenditures (TTM) | 3.00 |
| Free cash flow (TTM) | 920.41K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 23.20% |
| Return on Assets | 23.09% |
| Return on Invested Capital | 23.20% |
| Cash Return on Invested Capital | 2.85% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 32.24 |
| Daily high | 33.96 |
| Daily low | 28.61 |
| Daily Volume | 19K |
| All-time high | 41.11 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | 0.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NNNN | S&P500 | |
| Current price drop from All-time high | -30.41% | -0.89% |
| Highest price drop | -67.01% | -19.00% |
| Date of highest drop | 3 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -24.78% | -2.49% |
| Avg time to new high | 17 days | 6 days |
| Max time to new high | 46 days | 89 days |
COMPANY DETAILS
Marketcap
1.26B
Marketcap category
Small-cap
Description
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Employees
27
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner